Association between most prevalent side effects and number of chemotherapy sessions in women with breast neoplasia

International Journal of Development Research

Volume: 
09
Article ID: 
17427
4 pages
Research Article

Association between most prevalent side effects and number of chemotherapy sessions in women with breast neoplasia

Cristina Albuquerque Douberin, Liniker Scolfild Rodrigues da Silva, Talita Munique de Melo Rodrigues, Edivaldo Bezerra Mendes Filho, Eliana Lessa Cordeiro, Leandro Mangueira de Lacerda, Edjane Jerônimo dos Santos, Adriana Maria dos Santos, Luciana Maria da Silva, Marcelo Henrique Alves da Cunha, Diná Lyra da Trindade Silva and Cecília Cardoso de Carvalho

Abstract: 

Objective: This study aims to associate the most prevalent side effects with the duration of chemotherapy treatment of women with breast cancer assisted at the Pernambuco Cancer Hospital. Materials and Methods: This was a descriptive, cross-sectional study with a quantitative approach, conducted at the Outpatient Unit of a specialized clinic for breast pathology at the Pernambuco Cancer Hospital (PCH). The data collection procedure was performed by applying the Free and Informed Consent Term (FICT) and subsequently a collection instrument with information on the clinical treatment of women. Results: The study results revealed that a considerable portion of women, 192 of them (60.6%), received the diagnosis less than a year ago. When asked if they felt any kind of symptom, 284 patients (89.6%) stated that they had already felt or were feeling at the moment, among them, 238 (83.8%) indicated fatigue (tiredness) as a predominant symptom, followed by of nausea, which featured 218 markings (76.8%). Conclusion: Finally, it is clear that the symptoms, in general, became more prevalent in the lives of patients who had had few chemotherapy sessions.

Download PDF: